Immunodominant CD4+ T-cell responses to influenza a virus in healthy individuals focus on matrix 1 and nucleoprotein

Journal of Virology

Volumn 88, Issue 20, 2014, Pages 11760-11773

  Chen, Li ^a,b   Zanker, Damien ^b   Xiao, Kun ^b   Wu, Chao ^a   Zou, Quanming ^a   Chen, Weisan ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYTOKINE; EPITOPE; INFLUENZA VACCINE; MATRIX PROTEIN; MEMBRANE PROTEIN; NEUTRALIZING ANTIBODY; NUCLEOPROTEIN; VIRUS PROTEIN;

ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE MUTATION; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; INFLUENZA A; INFLUENZA VIRUS A; NONHUMAN; T LYMPHOCYTE; VACCINIA VIRUS; CELL CULTURE; IMMUNOLOGY;

CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; HUMANS; INFLUENZA A VIRUS; VIRAL PROTEINS;

EID: 84907445162     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01631-14     Document Type: Article

References (47)

1. Tamura S, Kurata T. 2004. Defense mechanisms against influenza virus infection in the respiratory tract mucosa. Jpn. J. Infect. Dis. 57:236-247.
2. Hamada H, Bassity E, Flies A, Strutt TM, Garcia-Hernandez MDL, McKinstry KK, Zou T, Swain SL, Dutton RW. 2013. Multiple redundant effector mechanisms of CD8+ T cells protect against influenza infection. J. Immunol. 190:296-306. http://dx.doi.org/10.4049/jimmunol.1200571.
3. Sun J, Braciale TJ. 2013. Role of T cell immunity in recovery from influenza virus infection. Curr. Opin. Virol. 3:425-429. http://dx.doi.org/10.1016/j.coviro.2013.05.001.
4. Swain SL, McKinstry KK, Strutt TM. 2012. Expanding roles for CD4(+) T cells in immunity to viruses. Nat. Rev. Immunol. 12:136-148. http://dx.doi.org/10.1038/nri3152.
5. McKinstry KK, Strutt TM, Kuang Y, Brown DM, Sell S, Dutton RW, Swain SL. 2012. Memory CD4+T cells protect against influenza through multiple synergizing mechanisms. J. Clin. Invest. 122:2847-2856. http: //dx.doi.org/10.1172/JCI63689.
6. Wilkinson TM, Li CK, Chui CS, Huang AK, Perkins M, Liebner JC, Lambkin-Williams R, Gilbert A, Oxford J, Nicholas B, Staples KJ, Dong T, Douek DC, McMichael AJ, Xu XN. 2012. Preexisting influenzaspecific CD4(+) T cells correlate with disease protection against influenza challenge in humans. Nat. Med. 18:274-280. http://dx.doi.org/10.1038 /nm.2612.
7. Wu C, Zanker D, Valkenburg S, Tan B, Kedzierska K, Zou QM, Doherty PC, Chen W. 2011. Systematic identification of immunodominant CD8+ T-cell responses to influenza A virus in HLA-A2 individuals. Proc. Natl. Acad. Sci. U. S. A. 108:9178-9183. http://dx.doi.org/10.1073 /pnas.1105624108.
8. Grant E, Wu C, Chan KF, Eckle S, Bharadwaj M, Zou QM, Kedzierska K, Chen W. 2013. Nucleoprotein of influenza A virus is a major target of immunodominant CD8(+) T-cell responses. Immunol. Cell Biol. 91: 184-194. http://dx.doi.org/10.1038/icb.2012.78.
9. Babon JA, Cruz J, Orphin L, Pazoles P, Co MD, Ennis FA, Terajima M. 2009. Genome-wide screening of human T-cell epitopes in influenza A virus reveals a broad spectrum of CD4(+) T-cell responses to internal proteins, hemagglutinins, and neuraminidases. Hum. Immunol. 70:711-721. http://dx.doi.org/10.1016/j.humimm.2009.06.004.
10. Lee LY, Ha DO, Simmons LAC, de Jong MD, Chau NV, Schumacher R, Peng YC, McMichael AJ, Farrar JJ, Smith GL, Townsend AR, Askonas BA, Rowland-Jones S, Dong T. 2008. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J. Clin. Invest. 118:3478-3490. http://dx.doi.org/10.1172/JCI32460.
11. Assarsson E, Bui HH, Sidney J, Zhang Q, Glenn J, Oseroff C, Mbawuike IN, Alexander J, Newman MJ, Grey H, Sette A. 2008. Immunomic analysis of the repertoire of T-cell specificities for influenzaAvirus in humans. J. Virol. 82:12241-12251. http://dx.doi.org/10.1128/JVI.01563-08.
12. Goulder PJ, Phillips RE, Colbert RA, McAdam S, Ogg G, Nowak MA, Giangrande P, Luzzi G, Morgan B, Edwards A, McMichael AJ, Rowland-Jones S. 1997. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 3:212-217. http://dx.doi.org/10.1038/nm0297-212.
13. Goulder PJ, Sewell AK, Lalloo DG, Price DA, Whelan JA, Evans J, Taylor GP, Luzzi G, Giangrande P, Phillips RE, McMichael AJ. 1997. Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation. J. Exp. Med. 185:1423-1433. http://dx.doi.org/10.1084/jem.185.8.1423.
14. Chen L, Li B, Yang WC, He JL, Li NY, Hu J, He YF, Yu S, Zhao Z, Luo P, Zhang JY, Li HB, Zeng M, Lu DS, Li BS, Guo H, Yang SM, Guo G, Mao XH, Chen W, Wu C, Zou QM. 2013. A dominant CD4+ T-cell response to Helicobacter pylori reduces risk for gastric disease in humans. Gastroenterology 144:591-600. http://dx.doi.org/10.1053/j.gastro.2012.12.002.
15. Yuwen H, Cox JH, Yewdell JW, Bennink JR, Moss B. 1993. Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene. Virology 195:732-744. http://dx.doi.org/10.1006 /viro.1993.1424.
16. Gerhard W, Yewdell J, Frankel ME, Webster R. 1981. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 290:713-717. http://dx.doi.org/10.1038/290713a0.
17. Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, Roederer M, Koup RA. 2003. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281:65-78. http://dx.doi.org/10.1016/S0022-1759(03)00265-5.
18. Pala P, Bodmer HC, Pemberton RM, Cerottini JC, Maryanski JL, Askonas BA. 1988. Competition between unrelated peptides recognized by H-2-Kd restricted T cells. J. Immunol. 141:2289-2294.
19. Kozlowski S, Corr M, Shirai M, Boyd LF, Pendleton CD, Berzofsky JA, Margulies DH. 1993. Multiple pathways are involved in the extracellular processing of MHC class I-restricted peptides. J. Immunol. 151:4033-4044.
20. Sant AJ, Chaves FA, Krafcik FR, Lazarski CA, Menges P, Richards K, Weaver JM. 2007. Immunodominance in CD4 T-cell responses: implications for immune responses to influenza virus and for vaccine design. Expert Rev. Vaccines 6:357-368. http://dx.doi.org/10.1586/14760584.6.3.357.
21. Shaw ML, Stone KL, Colangelo CM, Gulcicek EE, Palese P. 2008. Cellular proteins in influenza virus particles. PLoS Pathog. 4:e1000085. http://dx.doi.org/10.1371/journal.ppat.1000085.
22. Li P, Gregg JL, Wang N, Zhou D, O'Donnell P, Blum JS, Crotzer VL. 2005. Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing. Immunol. Rev. 207:206-217. http://dx.doi.org/10.1111/j.0105-2896.2005.00297.x.
23. Paludan C, Schmid D, Landthaler M, Vockerodt M, Kube D, Tuschl T, Munz C. 2005. Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 307:593-596. http://dx.doi.org/10.1126 /science.1104904.
24. Schmid D, Pypaert M, Munz C. 2007. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 26:79-92. http://dx.doi.org /10.1016/j.immuni.2006.10.018.
25. Munz C. 2012. Antigen processing for MHC class II presentation via autophagy. Front. Immunol. 3:9. http://dx.doi.org/10.3389/fimmu.2012.00009.
26. Menendez-Benito V, Neefjes J. 2007. Autophagy in MHC class II presentation: sampling from within. Immunity 26:1-3. http://dx.doi.org/10.1016/j.immuni.2007.01.005.
27. Teijaro JR, Verhoeven D, Page CA, Turner D, Farber DL. 2010. Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms. J. Virol. 84:9217-9226. http: //dx.doi.org/10.1128/JVI.01069-10.
28. Brown DM, Lee S, Garcia-Hernandez MDL, Swain SL. 2012. Multifunctional CD4 cells expressing gamma interferon and perforin mediate protection against lethal influenza virus infection. J. Virol. 86:6792-6803. http://dx.doi.org/10.1128/JVI.07172-11.
29. Soghoian DZ, Streeck H. 2010. Cytolytic CD4(+) T cells in viral immunity. Expert Rev. Vaccines 9:1453-1463. http://dx.doi.org/10.1586/erv.10.132.
30. Bot A, Bot S, Bona CA. 1998. Protective role of gamma interferon during the recall response to influenza virus. J. Virol. 72:6637-6645.
31. Seo SH, Webster RG. 2002. Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells. J. Virol. 76:1071-1076. http://dx.doi.org/10.1128/JVI.76.3.1071-1076.2002.
32. Chaves FA, Lee AH, Nayak JL, Richards KA, Sant AJ. 2012. The utility and limitations of current Web-available algorithms to predict peptides recognized by CD4 T cells in response to pathogen infection. J. Immunol. 188:4235-4248. http://dx.doi.org/10.4049/jimmunol.1103640.
33. Doolan DL, Southwood S, Chesnut R, Appella E, Gomez E, Richards A, Higashimoto YI, Maewal A, Sidney J, Gramzinski RA, Mason C, Koech D, Hoffman SL, Sette A. 2000. HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles. J. Immunol. 165:1123-1137. http://dx.doi.org/10.4049/jimmunol.165.2.1123.
34. Hammer J, Valsasnini P, Tolba K, Bolin D, Higelin J, Takacs B, Sinigaglia F. 1993. Promiscuous and allele-specific anchors in HLA-DRbinding peptides. Cell 74:197-203. http://dx.doi.org/10.1016/0092-8674(93)90306-B.
35. Wang P, Sidney J, Dow C, Mothe B, Sette A, Peters B. 2008. A systematic assessment ofMHCclass II peptide binding predictions and evaluation of a consensus approach. PLoS Comput. Biol. 4:e1000048. http://dx.doi.org /10.1371/journal.pcbi.1000048.
36. Wang P, Sidney J, Kim Y, Sette A, Lund O, Nielsen M, Peters B. 2010. Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinformatics 11:568. http://dx.doi.org/10.1186/1471-2105-11-568.
37. Roti M, Yang J, Berger D, Huston L, James EA, Kwok WW. 2008. Healthy human subjects have CD4+T cells directed against H5N1 influenza virus. J. Immunol. 180:1758-1768. http://dx.doi.org/10.4049/jimmunol.180.3.1758.
38. Gog JR, Rimmelzwaan GF, Osterhaus AD, Grenfell BT. 2003. Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A. Proc. Natl. Acad. Sci. U. S. A. 100:11143-11147. http://dx.doi.org/10.1073/pnas.1830296100.
39. Yang J, Huston L, Berger D, Danke NA, Liu AW, Disis ML, Kwok WW. 2005. Expression of HLA-DP0401 molecules for identification of DP0401 restricted antigen specific T cells. J. Clin. Immunol. 25:428-436. http://dx.doi.org/10.1007/s10875-005-6095-6.
40. Faner R, James E, Huston L, Pujol-Borrel R, Kwok WW, Juan M. 2010. Reassessing the role of HLA-DRB3 T-cell responses: evidence for significant expression and complementary antigen presentation. Eur. J. Immunol. 40:91-102. http://dx.doi.org/10.1002/eji.200939225.
41. Chow IT, James EA, Tan V, Moustakas AK, Papadopoulos GK, Kwok WW. 2012. DRB1*12:01 presents a unique subset of epitopes by preferring aromatics in pocket 9. Mol. Immunol. 50:26-34. http://dx.doi.org/10.1016/j.molimm.2011.11.014.
42. Yang J, James EA, Huston L, Danke NA, Liu AW, Kwok WW. 2006. Multiplex mapping of CD4 T cell epitopes using class II tetramers. Clin. Immunol. 120:21-32. http://dx.doi.org/10.1016/j.clim.2006.03.008.
43. Ge X, Tan V, Bollyky PL, Standifer NE, James EA, Kwok WW. 2010. Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus. J. Virol. 84:3312-3319. http://dx.doi.org/10.1128/JVI.02226-09.
44. Ge X, Gebe JA, Bollyky PL, James EA, Yang J, Stern LJ, Kwok WW. 2010. Peptide-MHC cellular microarray with innovative data analysis system for simultaneously detecting multiple CD4 T-cell responses. PLoS One 5:e11355. http://dx.doi.org/10.1371/journal.pone.0011355.
45. Alexander J, Bilsel P, del Guercio MF, Stewart S, Marinkovic-Petrovic A, Southwood S, Crimi C, Vang L, Walker L, Ishioka G, Chitnis V, Sette A, Assarsson E, Hannaman D, Botten J, Newman MJ. 2010. Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice. Vaccine 28:664-672. http://dx.doi.org/10.1016/j.vaccine.2009.10.103.
46. James EA, Moustakas AK, Berger D, Huston L, Papadopoulos GK, Kwok WW. 2008. Definition of the peptide binding motif within DRB1*1401 restricted epitopes by peptide competition and structural modeling. Mol. Immunol. 45:2651-2659. http://dx.doi.org/10.1016/j.molimm.2007.12.013.
47. Wang P, Sidney J, Dow C, Mothé B, Sette A, Peters B. 2008. A systematic assessment ofMHCclass II peptide binding predictions and evaluation of a consensus approach. PLoS Comput. Biol. 4:e1000048. http://dx.doi.org /10.1371/journal.pcbi.1000048.